| Authors | Kimberly R Warren, Robert W Buchanan, Stephanie Feldman, Robert R Conley, Jared Linthicum, Mary Patricia Ball, Fang Liu, Robert P McMahon, David A Gorelick, Marilyn A Huestis, Deanna L Kelly |
| Journal | Journal of clinical psychopharmacology
(J Clin Psychopharmacol)
Vol. 33
Issue 1
Pg. 118-20
(Feb 2013)
ISSN: 1533-712X [Electronic] United States |
| PMID | 23277241
(Publication Type: Letter, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
|
| Chemical References |
- Antipsychotic Agents
- Appetite Depressants
- CNR1 protein, human
- Cannabinoid Receptor Antagonists
- Piperidines
- Pyrazoles
- Receptor, Cannabinoid, CB1
- Rimonabant
|
| Topics |
- Adult
- Antipsychotic Agents
(adverse effects)
- Appetite Depressants
(adverse effects, therapeutic use)
- Body Mass Index
- Body Weight
(drug effects)
- Brain
(drug effects, metabolism)
- Cannabinoid Receptor Antagonists
(adverse effects, therapeutic use)
- Double-Blind Method
- Drug Inverse Agonism
- Eating
(drug effects)
- Energy Intake
(drug effects)
- Female
- Humans
- Male
- Middle Aged
- Overweight
(chemically induced, diagnosis, drug therapy, psychology)
- Pilot Projects
- Piperidines
(adverse effects, therapeutic use)
- Pyrazoles
(adverse effects, therapeutic use)
- Receptor, Cannabinoid, CB1
(antagonists & inhibitors, metabolism)
- Rimonabant
- Satiety Response
(drug effects)
- Schizophrenia
(diagnosis, drug therapy)
- Schizophrenic Psychology
- Signal Transduction
(drug effects)
- Treatment Outcome
|
